Hematologic Disease and Disorders: Clinical Trials

1 trial for Hematologic Disease and Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1

Follow Hematologic Disease and Disorders: new trials by email Literature Review of Hematologic Disease and Disorders trials Research Report on Hematologic Disease and Disorders

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Early Use of Tacrolimus in HLA-Mismatched Haploidentical Allogeneic Hematopoietic Transplantation With Post-Transplant Cyclophosphamide
Tacrolimus, Cyclophosphamide, Mycofenolate mofetil - Hematologic Disease and Disorders, Hematopoietic Cell Transplant
Phase 2RecruitingNorthside Hospital, Inc.202025-07-032026-10-14

Narrower conditions

Disease (1)  ·  Hematologic Diseases (1)

Broader conditions

Hemic and Lymphatic Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Cyclophosphamide (1)  ·  Tacrolimus (1)

Sponsors

Northside Hospital, Inc. (1)

Countries

United States (1)

Top investigators

Melhem Solh, MD (1)

Results publications

PMID 23233586, PMID 23423745, PMID 27318038, PMID 29421292, PMID 30953027, PMID 32645444, PMID 34262142, PMID 38281591, PMID 7742535, PMID 8877390